These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23594419)

  • 61. [Urinary investigations in the diagnosis and monitoring of monoclonal gammopathies in daily practice].
    Oudart JB; Quinquenel A; Lavalard E; Schneider N; Fromonot J; Ramont L; Maquart FX
    Ann Biol Clin (Paris); 2014; 72(2):147-52. PubMed ID: 24736135
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Once again, rare diseases provide a spotlight.
    Lal TR; Borger DK; Sidransky E
    Mol Genet Metab; 2016 May; 118(1):1-2. PubMed ID: 27017192
    [No Abstract]   [Full Text] [Related]  

  • 63. Prevalence of polyclonal gammopathy in polyneuropathy.
    Gorson KC; Ropper AH; Palmetshofer AK; Weinstein R
    Neurology; 1997 Dec; 49(6):1747. PubMed ID: 9409386
    [No Abstract]   [Full Text] [Related]  

  • 64. A case of bony lytic lesions in a patient with Gaucher disease.
    McGinnis E; Moshref Razavi H
    Clin Case Rep; 2019 Sep; 7(9):1685-1688. PubMed ID: 31534727
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lysosomal Storage Disorders and Malignancy.
    Pastores GM; Hughes DA
    Diseases; 2017 Feb; 5(1):. PubMed ID: 28933361
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Epidemiology of monoclonal gammopathies].
    Decaux O
    Rev Prat; 2018 Sep; 68(7):785-786. PubMed ID: 30869333
    [No Abstract]   [Full Text] [Related]  

  • 67. The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease.
    Nascimbeni F; Lugari S; Andreone P; Carubbi F
    Liver Int; 2021 Jan; 41(1):224-225. PubMed ID: 33091221
    [No Abstract]   [Full Text] [Related]  

  • 68. PCA-LBD in Gaucher disease type 1: a case description.
    Curti DG; Caso F; Malvaso A; Cardamone R; Martinelli V; Magnani G; Filippi M
    Neurol Sci; 2022 Jan; 43(1):715-718. PubMed ID: 34618252
    [No Abstract]   [Full Text] [Related]  

  • 69. A 30-Year-Old Carrier of Gaucher Disease with Multiple Myeloma.
    Chadha J; Sahai T; Schwimmer J; Shani D
    Case Rep Oncol Med; 2019; 2019():6469196. PubMed ID: 30906609
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gaucher disease: haematological presentations and complications.
    Thomas AS; Mehta A; Hughes DA
    Br J Haematol; 2014 May; 165(4):427-40. PubMed ID: 24588457
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gaucher disease and comorbidities: B-cell malignancy and parkinsonism.
    Cox TM; Rosenbloom BE; Barker RA
    Am J Hematol; 2015 Jul; 90 Suppl 1():S25-8. PubMed ID: 26096744
    [TBL] [Abstract][Full Text] [Related]  

  • 72. B cell lymphoma and myeloma in murine Gaucher's disease.
    Pavlova EV; Wang SZ; Archer J; Dekker N; Aerts JM; Karlsson S; Cox TM
    J Pathol; 2013 Sep; 231(1):88-97. PubMed ID: 23775597
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy.
    Pavlova EV; Archer J; Wang S; Dekker N; Aerts JM; Karlsson S; Cox TM
    J Pathol; 2015 Jan; 235(1):113-24. PubMed ID: 25256118
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gaucher disease and its treatment options.
    Bennett LL; Mohan D
    Ann Pharmacother; 2013 Sep; 47(9):1182-93. PubMed ID: 24259734
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hematological manifestations and complications of Gaucher disease.
    Linari S; Castaman G
    Expert Rev Hematol; 2016 Jan; 9(1):51-8. PubMed ID: 26565753
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gaucher disease.
    Nagral A
    J Clin Exp Hepatol; 2014 Mar; 4(1):37-50. PubMed ID: 25755533
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Management of Gaucher disease: enzyme replacement therapy.
    Zimran A; Elstein D
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():82-7. PubMed ID: 25345089
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10.
    Allen MJ; Myer BJ; Khokher AM; Rushton N; Cox TM
    QJM; 1997 Jan; 90(1):19-25. PubMed ID: 9093585
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gaucher disease: chemotactic factors and immunological cell invasion in a mouse model.
    Pandey MK; Jabre NA; Xu YH; Zhang W; Setchell KD; Grabowski GA
    Mol Genet Metab; 2014 Feb; 111(2):163-71. PubMed ID: 24079945
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.